Chief Operating Officer (Eidos Therapeutics and Calcilytix Therapeutics) @ (January 2024 - January 2026)
Senior Vice President, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @ (May 2022 - January 2024)
Vice President, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @ (January 2020 - May 2022)
Senior Director, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @ (August 2018 - January 2020)
Advisor @ (January 2018 - December 2020)
Advisor @ (January 2013 - December 2020)
New Products Planning @ (August 2014 - August 2018)
Business Development and Strategic Intelligence @ (June 2013 - August 2013)
Analyst @ (August 2010 - June 2012)
Research Assistant @ (October 2007 - June 2010)
Process Research and Development Engineer @ (June 2009 - September 2009)
Researcher Assistant @ (June 2007 - September 2007)
Ananth Sridhar Education
Harvard Business School
Master of Business Administration (MBA)
Stanford University
B.S. with Honors (Chemical Engineering)
Ananth Sridhar Skills
Data Analysis
Matlab
Biotechnology
Life Sciences
Molecular Biology
Leadership
Pharmaceutical Industry
Strategic Planning
Strategy
Microsoft Office
Ananth Sridhar Summary
Ananth Sridhar, based in United States, is currently a Chief Executive Officer, BridgeBio Endocrinology (Calcilytix Therapeutics) at BridgeBio. Ananth Sridhar brings experience from previous roles at BridgeBio. Ananth Sridhar holds a Master of Business Administration (MBA) @ Harvard Business School. With a robust skill set that includes Data Analysis, Matlab, Biotechnology, Life Sciences, Molecular Biology and more. Ananth Sridhar has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ananth Sridhar?
Find contact details for 700 million professionals.